NCT04586660 2025-10-01
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
Amgen
Phase 4 Active not recruiting
Clinical Trials
7 trialsNCT03301857 2024-05-20
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Amgen
Phase 4 Completed
NCT05813665 2023-04-19
A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone
Shanghai JMT-Bio Inc.
Phase 3 Not yet recruiting
NCT05402865 2022-06-02
A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone
Shanghai JMT-Bio Inc.
Completed
NCT03620149 2021-01-06
REDUCE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT03358212 2017-11-30
Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China
Peking University People's Hospital
Unknown
NCT03259152 2017-08-24
D-Gct
Hebei Medical University Third Hospital
Phase 3 Unknown